Atara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces Third Quarter 2022 Financial Results and Operational Progress
(NASDAQ: ATRA) Delayed: 9.60 -0.1 (1.03%)
Previous Close $9.70    52 Week High $40.80 
Open $9.57    52 Week Low $12.45 
Day High $9.66    P/E N/A 
Day Low $9.32    EPS $0.00 
Volume 8,974